Results 141 to 147 of about 2,579 (147)

Small glycomimetic antagonists of the cytomegalovirus glycoprotein UL141 prevent binding to TRAIL death receptor. [PDF]

J Biol Chem
Nemčovičová I, Kóňa J, Poláková M, Klunda T, Bitala A, Benko M, Lenhartová S, Nemčovič M.   +7 more
europepmc   +1 more source

Assessing the Potential of <i>N</i>-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent. [PDF]

ACS Pharmacol Transl Sci
Esposito A, Rossi A, Stabile M, Pinto G, De Fino I, Melessike M, Tamanini A, Cabrini G, Lippi G, Aureli M, Loberto N, Renda M, Galietta LJV, Amoresano A, Dechecchi MC, De Gregorio E, Bragonzi A, Guaragna A.   +17 more
europepmc   +1 more source

Oral supplement in healthy older adults to support physical fitness and mental wellbeing. [PDF]

Front Nutr
Lloyd AJ, Nash RJ, Warren-Walker A, Watson A, Martinez Martin MP, Davies C, Villarreal-Ramos B, Wilson T, Beckmann M.   +8 more
europepmc   +1 more source

Ro(a)d to New Functional Materials: Sustainable Isolation of High-Aspect-Ratio β-Chitin Microrods from Marine Algae. [PDF]

Bioengineering (Basel)
Ludwig J, Kauffmann F, Laschat S, Weiss IM.   +3 more
europepmc   +1 more source

Emerging Capabilities of Nonclassical Noncovalent Interactions and Asymmetric Catalysis in Stereoselective Glycosylations and Carbohydrate Functionalizations. [PDF]

Acc Chem Res
Sebastian AT, Loh CCJ.
europepmc   +1 more source

Bacterial pathogen deploys iminosugar galactosyrin to manipulate plant glycobiology

Sanguankiattichai N, Chandrasekar B, Sheng Y, Hardenbrook N, Tabak WWA, Krahn D, Drapal M, Buscaill P, Yamamoto S, Kato A, Nash R, Fleet G, Fraser P, Kaiser M, Zhang P, Preston GM, van der Hoorn RAL.   +16 more
europepmc   +1 more source